Drug Discovery Postdoctoral Fellowship
Drug Discovery Postdoctoral Fellowship supports postdoctoral researchers’ training in novel, early-stage drug discovery research to advance safe, effective treatments with potential for translation to humans.
Browse similar grants
Funder: PhRMA Foundation
Due Dates: October 30, 2026, at noon ET (Letter of intent) | March 2027 (Invited full application; exact date provided upon invitation)
Funding Amounts: $60,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports postdoctoral training in novel, early-stage drug discovery research with clear potential for translation to humans.
Key Information: Applicants must have a doctorate conferred on or after January 1, 2024, and at least two first-author publications.
Description
The PhRMA Foundation’s Drug Discovery Postdoctoral Fellowship supports multidisciplinary, collaborative research training at accredited U.S. universities. It aims to extend researchers’ drug discovery credentials while advancing efficacious, safe, and differentiated treatments for patients. The second 2027 funding cycle supports novel, early-stage research grounded in a therapeutically relevant hypothesis and with clear potential for translation to humans.
Research may address target identification and validation, disease mechanisms through single-cell and spatial multi-omics, hit and lead identification, molecular modeling, protein biochemistry, structural biology, and therapeutic pathways. Cell-based and animal studies may examine candidate mechanisms, effectiveness, safety, and toxicity; advanced imaging may investigate targets and drug distribution. AI and computational approaches must directly advance a therapeutic hypothesis, with computational work linked to feasible validation in human-relevant systems.
